About: 2019-novel coronavirus outbreak: A new challenge

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 2019-novel coronavirus outbreak: A new challenge Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	2019-novel coronavirus outbreak: A new challenge
Creator	Corcione, Silvia Lupia, Tommaso Scabini, Silvia De Rosa, Francesco Mornese Pinna, Simone Perri, Giovanni
Source	Elsevier; Medline; PMC
abstract	OBJECTIVES: Following the public health emergency declared by the World Health Organization and the recent outbreak by 2019-nCoV in China and through other 29 countries, we aimed to summarize the clinical aspects of novel beta-coronavirus infection and its possible clinical presentations together with suggested therapeutic algorithms for patients who may require antibiotic treatment. METHODS: We reviewed the currently available literature of microbiologically confirmed infections by 2019-ConV (or COVID-19) occurred at the time of writing (13 February 2020). A literature search was performed using the PubMed database and the Cochrane library. Search terms included %22novel coronavirus%22 or %222019-nCoV%22 or “COVID-19”. RESULTS: Published cases occurred mostly in males (age ranged from 8 to 92). Cardiovascular, digestive and endocrine system diseases were commonly reported, except previous chronic pulmonary diseases (e.g., COPD, asthma, bronchiectasis) that were surprisingly underreported. Fever was presented in all the case series available, flanked by cough, dyspnea, myalgias and fatigue. Multiple bilateral lobular and subsegmental areas of consolidation or bilateral ground-glass opacities were the main reported radiological features of 2019-nCoV, at least in the early phases of disease. CONCLUSIONS: The new 2019-nCoV epidemics is mainly associated with respiratory disease and few extrapulmonary signs. However, there is a low rate of associated pre-existing respiratory comorbidities.
has issue date	2020-03-07(xsd:dateTime)
bibo:doi	10.1016/j.jgar.2020.02.021
bibo:pmid	32156648
has license	no-cc
sha1sum (hex)	74d892305c62c72247aa1d35e1a42769638219d6
schema:url	https://doi.org/10.1016/j.jgar.2020.02.021
resource representing a document's title	2019-novel coronavirus outbreak: A new challenge
has PubMed Central identifier	PMC7102618
has PubMed identifier	32156648
schema:publication	J Glob Antimicrob Resist
resource representing a document's body	covid:74d892305c62c72247aa1d35e1a42769638219d6#body_text
is schema:about of	named entity 'pneumonia' named entity 'superinfection' named entity 'COUGH' named entity 'RECENT' named entity 'CLINICAL ASPECTS' named entity 'RISK OF' named entity 'DYSPNEA' named entity 'NEARBY' named entity 'infection' named entity 'patients' named entity 'therapeutic' named entity 'summarize' named entity 'dyspnea' named entity 'antibiotic' named entity 'coronavirus' named entity 'cough' named entity 'antibiotic treatment' named entity 'public health emergency' named entity 'signs of disease' named entity 'Coronavirus Outbreak' named entity 'comorbidity' named entity 'lung parenchyma' named entity 'case series' named entity 'Wuhan epidemic' named entity 'acute illness' named entity 'respiratory symptoms' named entity 'CXR' named entity 'nausea' named entity 'fatality rate' named entity 'SARS-CoV' named entity 'computed tomography' named entity 'Taiwan' named entity 'procalcitonin' named entity '2019-nCoV' named entity 'epidemics' named entity 'COVID' named entity 'case series' named entity 'diarrhoea' named entity '2019-nCoV' named entity 'chronic illness' named entity 'Philippines' named entity 'AST and ALT' named entity 'hypertriglyceridemia' named entity 'epidemic' named entity 'cough' named entity 'acute phase' named entity 'CDC' named entity 'China' named entity 'Acinetobacter baumannii' named entity 'betacoronavirus' named entity 'abdominal discomfort' named entity 'asthma' named entity '1.2' named entity 'symptom' named entity 'cardiovascular risk' named entity 'vomiting' named entity 'Hubei province, China' named entity 'signs and symptoms' named entity 'underlying condition' named entity 'cardiovascular' named entity 'coronavirus' named entity 'MERS-CoV' named entity '2019-nCoV' named entity 'Dyspnea' named entity 'pneumonia' named entity 'CoV' named entity 'epidemic' named entity 'France' named entity 'nausea' named entity 'epidemic' named entity '2019-nCoV' named entity 'infection' named entity 'infection control' named entity 'diabetes' named entity 'erythrocyte sedimentation rate' named entity 'antifungal treatment'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software